Early differentiation between rejection and infection in liver transplant patients by serum and biliary cytokine patterns

Transplantation

Volumn 75, Issue 1, 2003, Pages 146-151

  Warlé, Michiel C ^a   Metselaar, Herold J ^a   Hop, Wim C J ^b   Gyssens, Inge C ^a   Kap, Marcel ^a   Kwekkeboom, Jaap ^a   De Rave, Sjoerd ^a   Zondervan, Pieter E ^a   Ijzermans, Jan N M ^a   Tilanus, Hugo W ^a   Bouma, Gerda J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; ARTICLE; BLOOD SAMPLING; CELL DIFFERENTIATION; CYTOKINE RELEASE; FEMALE; GRAFT REJECTION; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INFECTIOUS COMPLICATION; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURGICAL PATIENT; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; BACTERIAL INFECTIONS; BILE; CYTOKINES; DIAGNOSIS, DIFFERENTIAL; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; INTERCELLULAR ADHESION MOLECULE-1; LIVER TRANSPLANTATION; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTORS, INTERLEUKIN-2;

EID: 0037439655     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200301150-00026     Document Type: Article

References (30)

1. Wiesner RH, Demetris AJ, Belle SH, et al. Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome. Hepatology 1998; 28; 638.
2. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998; 338: 1741.
3. Winston DJ, Emmanouilides C, Busuttil RW. Infections in liver transplant recipients. Clin Infect Dis 1995; 21: 1077.
4. Adams DH, Wang L, Hubscher SG, et al. Soluble interleukin-2 receptors in serum and bile of liver transplant recipients. Lancet 1989; 1: 469.
5. Perkin JD, Nelson DL, Rakela J, et al. Soluble interleukin-2 receptor levels as an indicator of liver allograft rejection. Transplantation 1989; 47: 77.
6. Platz K-P, Mueller AR, Rossaint R, et al. Cytokine pattern during rejection and infection after liver transplantation - improvements in postoperative monitoring? Transplantation 1996; 62: 1441.
7. Mueller AR, Platz K-P, Wiehe I, et al. Cytokine pattern in patients with infections after liver transplantation. Transpl Int 1996; 9: 126.
8. Imagawa DK, Millis JM, Olthoff KM, et al. The role of tumor necrosis factor in allograft rejection. Transplantation 1990; 50: 219.
9. Tilg H, Vogel W, Aulitsky WE, et al. Evaluation of cytokines and cytokine-induced secondary messages in sera of patients after liver transplantation. Transplantation 1990; 49: 1074.
10. Kraus TH, Mehrabi A, Wermann AM, et al. Evaluation of soluble tumor necrosis factor receptors after orthotopic liver transplantation. Transplant Proc 1992; 24: 2539.
11. Grenz A, Schenk M, Zipfel A, et al. TNF-alpha and its receptors mediate graft rejection and loss after liver transplantation. Clin Chem Lab Med 2000; 38: 1183.
12. Tilg H, Nordberg J, Vogel W, et al. Circulating serum levels of interleukin 6 and C-reactive protein after liver transplantation. Transplantation 1992; 54: 142.
13. Kita Y, Iwaki Y, Demetris AJ, et al. Evaluation of sequential serum interleukin-6 levels in liver allograft recipients. Transplantation 1994; 57: 1037.
14. Umeshita K, Monden M, Tono T, et al. Determination of the presence of interleukin-6 in bile after orthotopic liver transplantation. Ann Surg 1996; 223: 204.
15. Tilg H, Ceska M, Vogel W, et al. Interleukin-8 serum concentrations after liver transplantation. Transplantation 1992; 53: 800.
16. Adams DH, Hubscher SG, Shaw J, et al. Intercellular adhesion molecule 1 on liver allografts during rejection. Lancet 1989; 2: 1122.
17. Adams DH, Mainolfi E, Elias E, et al. Detection of circulating intercellular adhesion molecule-1 after liver transplantation-evidence of local release within the liver during graft rejection. Transplantation 1993; 55: 83.
18. Martinez OM, Villaneuva JC, Quinn M, et al. Soluble ICAM-1 and soluble HLA class I as indicators of immune activation in liver allograft recipients. Hepatology 1993; 18: 19.
19. Lang T, Krams SM, Villaneuva JC, et al. Differential patterns of circulating ICAM-1 and vascular ICAM-1 during liver allograft rejection. Transplantation 1995; 59: 584.
20. Ninova D, Krom RAF, Wienser RH, et al. Hepatic allograft rejection is associated with increased levels of soluble ICAM-1. Liver Transpl Surg 1995; 1: 290.
21. Mueller AR, Platz KP, Haller GW, et al. Adhesion molecules during adverse events after human liver transplantation. Transplant Proc 1997; 29: 2822.
22. Navarro VJ, Silver D, Langnas AN, et al. A pilot study of soluble adhesion molecules as surrogate markers for acute liver allograft rejection. Transplantation 1998; 65: 776.
23. Goto S, Noguchi T, Lynch SV, et al. Is regular measurement of adhesion molecules and cytokines useful to predict post-liver transplant complications? Transplant Proc 1998; 30: 2975.
24. Demetris A, Adams D, Bellamy C, et al. Update of the International Banff Schema for Liver Allograft Rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology 2000; 31: 792.
25. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16: 128.
26. Horan TC, Gaynes RP, Martone WJ, et al. CDC definitions of nosocomial surgical site infections. Am J Infect Control 1992; 20: 271.
27. Tartaglia LA, Goeddel DV. Two TNF receptors. Immunol Today 1992; 13: 151.
28. Diez-Ruiz A, Tilz GP, Zangerle R, et al. Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. Eur J Haematol 1995; 54: 1.
29. Bagglioni M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 1989; 84: 1045.
30. Seth R, Raymond FD, Makgoba W. Circulating ICAM-1 isoforms: Diagnostic prospects for inflammatory and immune disorders. Lancet 1991; 338: 83.